Clinical Trial Update: Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart Disease [Phase 3]

View source ↗

Summary

This document notes that a Phase 3 trial of lycopene/Ateronon for secondary prevention of coronary heart disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• Lycopene/Ateronon (lycopene)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Coronary Heart Disease | Phase 3 | Status: COMPLETED